Patent · US Active

Agent for suppressing expression of dominant mutant gene

US9238812B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

LSIP, LLC · JP

Inventors

Hirohiko Hohjoh · Tokyo, JP
Masaki Takahashi · Yokohama, JP

Key dates

Filing date	Sep 28, 2011
Grant date	Jan 19, 2016
Priority date	—
Expiry date	Sep 28, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An RNAi molecule that can selectively and effectively suppress only the expression of a particular dominant mutant gene, while permitting the expression of the wild-type gene or a desired mutant gene, and a design method thereof is presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.